By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeuroDerm Ltd. 

Ofakim      Israel
Phone: 925-270-0519 Fax: 925-290-1209



Company News
NeuroDerm (NDRM) Announces Start Of Patient Enrollment In Phase II Trial Of ND0612H For Advanced Parkinson’s Disease 12/30/2015 11:53:59 AM
NeuroDerm (NDRM) CEO To Present At Upcoming Investor Conferences 11/13/2015 10:06:44 AM
NeuroDerm (NDRM) Announces Third Quarter 2015 Financial Results 11/11/2015 8:40:41 AM
NeuroDerm (NDRM) Announces Streamlined U.S. Development Plan Following FDA Feedback On ND0612H And ND0612L For The Treatment Of Parkinson's Disease 11/11/2015 8:06:43 AM
NeuroDerm (NDRM) Announces 2015 Annual General Meeting Of Shareholders 9/24/2015 9:42:38 AM
NeuroDerm (NDRM) Announces Second Quarter 2015 Financial Results And Provides Corporate Update 8/6/2015 11:13:46 AM
NeuroDerm (NDRM) To Host Second Quarter 2015 Financial Results Conference Call On August 6, 2015 7/30/2015 8:06:53 AM
NeuroDerm (NDRM) Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/22/2015 7:12:45 AM
NeuroDerm (NDRM) Announces Pricing Of Public Offering 7/16/2015 7:45:30 AM
NeuroDerm (NDRM) Files Registration Statement For Proposed Follow-On Offering 7/6/2015 7:14:58 AM